Home / Shop / Anti Cancer / PERZEA 420 MG

PERZEA 420 MG

₹23,000.00 ₹29,990.00 Save ₹6,990.00
Perzea 420mg Injection contains Pertuzumab, a monoclonal antibody used to treat HER2-positive breast cancer, is an injection. For patients with HER2-positive breast cancer, either in the metastatic stage or as part of neoadjuvant/adjuvant therapy, it is frequently administered in conjunction with other drugs such trastuzumab and chemotherapy.
Across the clinical settings represented in this database, Pertuzumab is associated with HER2-positive early and metastatic breast cancer; HER2-positive metastatic gastric cancer in selected combinations/regions. Its pharmacology is summarized by the fact that it binds HER2 at a different extracellular domain from trastuzumab and blocks receptor dimerization. HER2 biology is central to treatment selection, and the clinical role depends on the tumor's HER2 status and disease setting. The medicine is classified as Targeted Therapy; HER2-Directed Therapy; Monoclonal Antibody and belongs to the HER2 monoclonal antibody group. The associated tumor types are Breast; Gastric/GEJ, while the documented regimen examples are TCHP; THP; trastuzumab + pertuzumab + taxane; maintenance combinations. These details place the agent within specific treatment pathways rather than describing a generalized use across oncology. Molecular and disease-specific eligibility can therefore be more important than tumor location alone when the treatment is considered. Any selection criterion explicitly included in the indication—whether molecular, receptor-based, disease-stage related, or dependent on prior therapy—should be retained when interpreting the record. Related agents may have overlapping indications but still differ in target or clinical positioning. This description is intended for professional reference and avoids individualized prescribing recommendations. Current labels and disease-specific guidelines should be consulted because accepted uses can change with new evidence and regulatory updates.
Therapy Category Targeted Therapy, Her2-Directed Therapy, Monoclonal Antibody
Protocols/Regimens Tchp, Thp, Trastuzumab + Pertuzumab + Taxane, Maintenance Combinations
Primary Indications Her2-Positive Early And Metastatic Breast Cancer, Her2-Positive Metastatic Gastric Cancer In Selected Combinations/Regions
Cancer/Tumor Types Breast, Gastric/Gej
Salt / Active Composition PERTUZUMAB
Strength / Dosage 420
Dosage Form Injection
Prescription Required Yes

Complete Your Order

PERZEA 420 MG
PERZEA 420 MG

₹23,000.00 × 1 = ₹23,000.00

Accepted formats: PDF, JPG, PNG (Max 5MB)
Added to cart successfully!

Book Your Consultation Now

×

✔ 15+ Years of Surgical Experience

✔ All Insurances Accepted

Cancer Medicine

My Cart

0 items
100% Genuine Cold-Chain Verified Express Delivery

Saved Medicines